Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0SL8X
|
|||
Former ID |
DNCL001916
|
|||
Drug Name |
Edoxaban tosylate
|
|||
Synonyms |
480449-71-6; Edoxaban (tosylate); Edoxaban TsOH; Edoxaban tosilate; UNII-32W99UE810; CHEBI:85975; 32W99UE810; SAVAYSA; Edoxaban tosylate [USAN]; Edoxaban TsOH salt; edoxaban monotosylate; edoxaban p-toluenesulfonate; edoxaban 4-toluenesulfonate; SCHEMBL330918; CHEMBL2105682; DTXSID10197399; ZLFZITWZOYXXAW-QXXZOGQOSA-N; BCP14472; C24H30ClN7O4S.C7H8O3S; 3601AH; HY-10264A; AKOS022186217; CS-1332; W-5624; Ethanediamide, N1-(5-chloro-2-pyridinyl)-N2-((1S,2R,4S)-4-((dimethylamino)carbonyl)- 2-(((4,5,6,7
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Embolism [ICD-11: JB42; ICD-10: O88, O88.8] | Approved | [1] | |
Stroke [ICD-11: 8B20; ICD-10: I64] | Approved | [1] | ||
Venous thromboembolism [ICD-11: BD72] | Approved | [1] | ||
Company |
Daiichi Sankyo
|
|||
Structure |
Download2D MOL |
|||
Formula |
C31H38ClN7O7S2
|
|||
Canonical SMILES |
CC1=CC=C(C=C1)S(=O)(=O)O.CN1CCC2=C(C1)SC(=N2)C(=O)NC3CC(CCC3NC(=O)C(=O)NC4=NC=C(C=C4)Cl)C(=O)N(C)C
|
|||
InChI |
1S/C24H30ClN7O4S.C7H8O3S/c1-31(2)24(36)13-4-6-15(27-20(33)21(34)30-19-7-5-14(25)11-26-19)17(10-13)28-22(35)23-29-16-8-9-32(3)12-18(16)37-23;1-6-2-4-7(5-3-6)11(8,9)10/h5,7,11,13,15,17H,4,6,8-10,12H2,1-3H3,(H,27,33)(H,28,35)(H,26,30,34);2-5H,1H3,(H,8,9,10)/t13-,15-,17+;/m0./s1
|
|||
InChIKey |
ZLFZITWZOYXXAW-QXXZOGQOSA-N
|
|||
CAS Number |
CAS 480449-71-6
|
|||
PubChem Compound ID | ||||
PubChem Substance ID | ||||
ChEBI ID |
CHEBI:85975
|
|||
ADReCS Drug ID | BADD_D00746 |
References | Top | |||
---|---|---|---|---|
REF 1 | Clinical pipeline report, company report or official report of Daiichi Sankyo. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.